Inotiv
NOTV
$4.27
Share price
2.64%
Change (1 day)
-24.16%
Change (1 year)
Categories
P/S ratio for Inotiv (NOTV)
P/S ratio as of May 2024 (TTM): 0.1833
According to Inotiv's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.183347. At the end of 2023 the company had a P/S ratio of 0.1618.
P/S ratio history for Inotiv from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.1618 | -25.01% |
| 2022 | 0.2157 | -96.72% |
| 2021 | 6.57 | 214.34% |
| 2020 | 2.09 | 87.2% |
| 2019 | 1.12 | 153.92% |
| 2018 | 0.4397 | -48.97% |
| 2017 | 0.8615 | 199.75% |
| 2016 | 0.2874 | -49.28% |
| 2015 | 0.5666 | -22.07% |
| 2014 | 0.7271 | -23.47% |
| 2013 | 0.9501 | 141.73% |
| 2012 | 0.3930 | 47.44% |
| 2011 | 0.2666 | -34.35% |
| 2010 | 0.4060 | 138.95% |
| 2009 | 0.1699 | 0.77% |
| 2008 | 0.1686 | -82.56% |
| 2007 | 0.9667 | 57.85% |
| 2006 | 0.6124 | -4.82% |
| 2005 | 0.6434 | 0.6% |
| 2004 | 0.6396 | 10.82% |
| 2003 | 0.5771 | 26.48% |
| 2002 | 0.4563 | -63.2% |
| 2001 | 1.24 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |
 NRC Health
NRC | 5.62 | 2,964.37% | 🇺🇸 USA |